The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
The bmi-1 gene was first isolated as an oncogene that cooperates with c-myc in the generation of mouse lymphomas. We subsequently identified Bmi-1 as a transcriptional repressor belonging to the mouse Polycomb group. The Polycomb group comprises an important, conserved set of proteins that are required to maintain stable repression of specific target genes, such as homeobox-cluster genes, during development. In mice, the absence of bmi-1 expression results in neurological defects and severe proliferative defects in lymphoid cells, whereas bmi-1 overexpression induces lymphomas. Here we show that bmi-1-deficient primary mouse embryonic fibroblasts are impaired in progression into the S phase of the cell cycle and undergo premature senescence. In these fibroblasts and in bmi-1-deficient lymphocytes, the expression of the tumour suppressors p16 and p19Arf, which are encoded by ink4a, is raised markedly. Conversely, overexpression of bmi-1 allows fibroblast immortalization, downregulates expression of p16 and p19Arf and, in combination with H-ras, leads to neoplastic transformation. Removal of ink4a dramatically reduces the lymphoid and neurological defects seen in bmi-1-deficient mice, indicating that ink4a is a critical in vivo target for Bmi-1. Our results connect transcriptional repression by Polycomb-group proteins with cell-cycle control and senescence.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Although specific mechanisms are as yet unknown, the senescence response appears to result in a reorganization of chromatin, at least some aspects of which require pRB activity (Jacobs et al., 1999; Leung et al., 2001; Bandyopadhyay et al., 2002; Itahana et al., 2003; Narita et al., 2003; Zhang et al., 2003, 2005).”
From Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors (2005) · cites this paper as Jacobs et al., 1999
In the citing paper
“Therefore, p16INK4A mediated senescence can be induced via disruption of PRC1/PRC2 complex components such as CBX7, BMI1 or EZH2 followed by decrease in levels of H3K27me3 (Jacobs et al., 1999; Bracken et al., 2003, 2007; Gil et al., 2004).”
From Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype (2021) · cites this paper as Jacobs et al., 1999
In the citing paper
“The molecular mechanisms underlying this derepression are not completely understood but have been associated with loss of polycomb group of proteins but independent of p53 (Jacobs et al., 1999; Bracken et al., 2007).”
From Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype (2021) · cites this paper as Jacobs et al., 1999
In the citing paper
“Because several studies have established a role for the polycomb group protein Bmi1 in the regulation of p16Ink4a (26–28), we analyzed the levels of Bmi1.”
From Age-Dependent Decline in β-Cell Proliferation Restricts the Capacity of β-Cell Regeneration in Mice (2009) · cites this paper as [27]
In the citing paper
“Overexpression of BMI1 [80], CBX7 [81], or CBX8 [82] results in the direct repression of p16 and senescence delay in human and mouse cells.”
From Mechanisms and Regulation of Cellular Senescence (2021) · cites this paper as [80]
Citations
Cites
A biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218
Role of the INK4a Locus in Tumor Suppression and Cell Mortality
Serrano, M., Lee, H.-W., Chin, L., Cordon-Cardo, C., Beach, D., & DePinho, R. A. (1996) · Cell · doi:10.1016/s0092-8674(00)81079-x · Cited by 1,585
Self-citationTumor Suppression at the Mouse INK4a Locus Mediated by the Alternative Reading Frame Product p19
Kamijo, T., Zindy, F., Roussel, M. F., Quelle, D. E., Downing, J. R., Ashmun, R. A., Grosveld, G., & Sherr, C. J. (1997) · Cell · doi:10.1016/s0092-8674(00)80452-3 · Cited by 1,566
Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization
Zindy, F., Eischen, C. M., Randle, D. H., Kamijo, T., Cleveland, J. L., Sherr, C. J., & Roussel, M. F. (1998) · Genes & Development · doi:10.1101/gad.12.15.2424 · Cited by 1,245
Alcorta, D. A., Xiong, Y., Phelps, D., Hannon, G., Beach, D., & Barrett, J. C. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.24.13742 · Cited by 1,008
van der Lugt, N. M., Domen, J., Linders, K., van Roon, M., Robanus-Maandag, E., te Riele, H., van der Valk, M., Deschamps, J., Sofroniew, M., & van Lohuizen, M. (1994) · Genes & Development · doi:10.1101/gad.8.7.757 · Cited by 781
Identification of cooperating oncogenes in Eμ-myc transgenic mice by provirus tagging
van Lohuizen, M., Verbeek, S., Scheljen, B., Wientjens, E., van der Guidon, H., & Berns, A. (1991) · Cell · doi:10.1016/0092-8674(91)90382-9 · Cited by 762
Genetic alterations of cyclins, cyclin-dependent kinases, and Cdk inhibitors in human cancer
(1996) · Advances in cancer research · doi:10.1016/s0065-230x(08)60352-8 · Cited by 752
Regulation of p16 CDKN2 Expression and Its Implications for Cell Immortalization and Senescence
Hara, E., Smith, R., Parry, D., Tahara, H., Stone, S., & Peters, G. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.3.859 · Cited by 733
Cited by
Items 801–900 of 1,001
Ring1b bookmarks genes in pancreatic embryonic progenitors for repression in adult β cells
van Arensbergen, J., García-Hurtado, J., Maestro, M. A., Correa-Tapia, M., Rutter, G. A., Vidal, M., & Ferrer, J. P. (2012) · Genes & Development · doi:10.1101/gad.206094.112 · Cited by 37
“For viable genetic mutations, including Bmi1 / or conditionally inactive Ezh2 mice, studies have so far largely uncovered severe self-renewal defects (e.g., Jacobs et al. 1999; Chen et al. 2009; Dhawan et al. 2009).”
BackgroundBmi-1 induces radioresistance in MCF-7 mammary carcinoma cells
LIU, Z.-G., LIU, L., XU, L.-H., YI, W., TAO, Y.-L., TU, Z.-W., LI, M.-Z., ZENG, M.-S., & XIA, Y.-F. (2012) · Oncology Reports · doi:10.3892/or.2011.1615 · Cited by 36
“Many studies have demonstrated that Bmi-1 protein regulates the INK4a/ARF locus, which encodes the two tumor suppressors, p16 INK4a and p14 ARF (p19 ARF in mouse), which act in pRb and p53 cell cycle control pathways, respectively (8,9).”
Disruptive chemicals, senescence and immortality
Carnero, A., Blanco-Aparicio, C., Kondoh, H., Lleonart, M. E., Martinez-Leal, J. F., Mondello, C., Scovassi, A. I., Bisson, W. H., Amedei, A., Roy, R., et al. (2015) · Carcinogenesis · doi:10.1093/carcin/bgv029 · Cited by 29
Glioma stem cell signaling: therapeutic opportunities and challenges
Dietrich, J., Diamond, E. L., & Kesari, S. (2010) · Expert Review of Anticancer Therapy · doi:10.1586/era.09.190 · Cited by 39
Xu, Z., Zhou, Z., Zhang, J., Xuan, F., Fan, M., Zhou, D., Liuyang, Z., Ma, X., Hong, Y., Wang, Y., et al. (2020) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.11.018 · Cited by 36
MIG-32 and SPAT-3A are PRC1 homologs that control neuronal migration inCaenorhabditis elegans
Karakuzu, O., Wang, D. P., & Cameron, S. (2009) · Development · doi:10.1242/dev.029363 · Cited by 36
“…system Bmi-1 is required for the self-renewal of neural stem cells (Molofsky et al., 2005; Molofsky et al., 2003), and epigenetic regulation of the cell cycle is a crucial function of Bmi-1 in the hematopoietic and nervous systems (Jacobs et al., 1999; Molofsky et al., 2005; Molofsky et al., 2003).”
BackgroundThe Synovial Sarcoma-Associated SYT-SSX2 Oncogene Antagonizes the Polycomb Complex Protein Bmi1
Barco, R., Garcia, C. B., & Eid, J. E. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005060 · Cited by 36
“These increases in protein level are thought to result in the aberrant silencing of tumor suppressor genes that would normally prevent carcinogenesis [15].”
BackgroundAt the stem of youth and health
Beltrami, A. P., Cesselli, D., & Beltrami, C. A. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.10.005 · Cited by 39
“…is upregulated by different senescence triggers (e.g. activated oncogenes, DNA damage, dysfunctional telomeres, and ROS) through at least two different pathways (i.e. PRCs, see previous discussion, and stress activated kinases) (Jacobs et al., 1999; Bulavin et al., 2004; Bracken et al., 2007).”
BackgroundSasaki, M., Matsubara, T., Yoneda, N., Nomoto, K., Tsuneyama, K., Sato, Y., & Nakanuma, Y. (2012) · Histopathology · doi:10.1111/his.12016 · Cited by 40
“Recent studies have shown that representative PcG proteins such as enhancer of zeste homolog 2 (EZH2) and Bmi1 interact with the pathways of key elements that control cell growth and proliferation, such as the Rb and p16 genes.(2,4) Aberrant expression of EZH2 is regarded as a potential marker of advanced or aggressiv…”
BackgroundEberle-Singh, J. A., Sagalovskiy, I. R., Maurer, H. C., Sastra, S. A., Palermo, C. F., Decker-Farrell, A. R., Kim, M. J., Sheedy, J., Mollin, A., Cao, L., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-3281 · Cited by 37
YY1 helps to bring loose ends together: Figure 1.Preprint
Calame, K. L., & Atchison, M. L. (2007) · Genes & Development · doi:10.1101/gad.1559007 · Cited by 37
“It should be noted that the PcG protein Bmi-1 can also control cell proliferation and is known to be necessary for hematopoietic stem cell self-renewal (Jacobs et al. 1999; Iwama et al. 2004).”
BackgroundBmi1 is required for the initiation of pancreatic cancer through an Ink4a-independent mechanism
Bednar, F., Schofield, H. K., Collins, M. A., Yan, W., Zhang, Y., Shyam, N., Eberle-Singh, J. A., Almada, L. L., Olive, K. P., Bardeesy, N. M., et al. (2015) · Carcinogenesis · doi:10.1093/carcin/bgv058 · Cited by 37
“Bmi1−/− mice have severe neurologic and hematopoietic developmental defects (10), which are at least partially reversed when the BMI1-deficient mice are bred onto an Ink4a/ Arf null background (9).”
Histone demethylase JMJD3 at the intersection of cellular senescence and cancer
Perrigue, P. M., Najbauer, J., & Barciszewski, J. (2016) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2016.03.002 · Cited by 36
Bmi-1 overexpression as an efficient prognostic marker in patients with nonsmall cell lung cancer
Zhang, X., Tian, T., Sun, W., Liu, C., & Fang, X. (2017) · Medicine · doi:10.1097/md.0000000000007346 · Cited by 35
“Bmi-1 overexpression could promote cell proliferation and induce leukemia initiation through the ink4a locus.([10]) Bmi-1 was also involved in the pathogenesis of medulloblastomas by activation of the sonic hedgehog pathway.”
BackgroundBmi1 Deficient Mice Exhibit Male Infertility
Dai, X., Zhang, Q., Yu, Z., Sun, W., Wang, R., & Miao, D. (2018) · International Journal of Biological Sciences · doi:10.7150/ijbs.23325 · Cited by 38
“One critical target of Bmi1 is Ink4a/Arf, which encodes the cell cycle inhibitors p16ink4a and p19Arf [28].”
BackgroundInfluentialShao, Y., Zhang, D., Li, X., Yang, J., Chen, L., Ning, Z., Xu, Y., Deng, G., Tao, M., Zhu, Y., et al. (2018) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.8b00302 · Cited by 37
Marengo, B., Monti, P., Miele, M., Menichini, P., Ottaggio, L., Foggetti, G., Pulliero, A., Izzotti, A., Speciale, A., Garbarino, O., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-32195-7 · Cited by 36
The Expansion and Maintenance of Antigen‐Selected CD8+ T Cell Clones
Fearon, D. T. (2007) · Advances in immunology · doi:10.1016/s0065-2776(07)96003-4 · Cited by 38
“It maintains self-renewing hematopoietic, cerebellar, and leukemic stem cells (Lessard and Sauvagneau, 2003; Molofsky et al., 2003; Park et al., 2003) by suppressing transcription of the INK4b-Arf-INK4a tumor suppressor locus whose protein products regulate pRb and p53 (Jacobs et al., 1999a).”
Lv, J., Cao, X., Ji, L., Zhu, B., Wang, D., Tao, L., & Li, S. (2011) · Medical Oncology · doi:10.1007/s12032-010-9816-5 · Cited by 35
“component of the polycomb repressive complex1 (PRC1), was initially identified as an oncogene cooperating with c-Myc through negatively regulating the suppressor protein expression, such as the p16INk4a and p19ARF, which are thought to regulate p53 and Rb signal pathway by cooperating with c-myc [19]; moreover, Bmi-1…”
BackgroundBmi1 reprograms CML B-lymphoid progenitors to become B-ALL–initiating cells
Sengupta, A., Ficker, A. M., Dunn, S. K., Madhu, M., & Cancelas, J. A. (2011) · Blood · doi:10.1182/blood-2011-06-359232 · Cited by 36
Dong, Q., Sharma, S. P., Liu, H., Chen, L., Gu, B., Sun, X., & Wang, G. (2013) · Toxicology Letters · doi:10.1016/j.toxlet.2013.10.014 · Cited by 36
Disruption of E2F signaling suppresses the INK4a-induced proliferative defect in M33-deficient mice
Coré, N., Joly, F., Boned, A., & Djabali, M. (2004) · Oncogene · doi:10.1038/sj.onc.1207998 · Cited by 37
“Absence of bmi-1 causes upregulation of p16INK4a and p19ARF expression, leading to impaired proliferation and premature entry of bmi-1-null MEFs into senescence as well as severe proliferation defects in the hematopoietic system (Jacobs et al., 1999a).”
BackgroundInfluentialTelomere length maintenance in stem cell populations
Allen, N. D., & Baird, D. M. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.02.004 · Cited by 36
Chromatin‐modifying proteins in cancer
Fog, C. K., Jensen, K. T., & Lund, A. H. (2007) · Apmis · doi:10.1111/j.1600-0463.2007.apm_776.xml.x · Cited by 37
Dynamics of ARF regulation that control senescence and cancer
Ko, A., Han, S. Y., & Song, J. (2016) · BMB Reports · doi:10.5483/bmbrep.2016.49.11.120 · Cited by 35
“cycle progression and enter premature senescence, which are rescued by ARF depletion (21).”
BackgroundZhai, R., Tang, F., Gong, J., Zhang, J., Lei, B., Li, B., Wei, Y., Liang, X., Tang, B., & He, S. (2016) · OncoTargets and Therapy · doi:10.2147/ott.s110985 · Cited by 35
“BMI1 inhibits CDKN2A (a gene encoding the tumor suppressors p16INK4a and p19Arf), and induces telomerase activity to regulate cell-cycle progression, apoptosis, senescence, and immortalization.(3,4) A large number of studies have shown that BMI1 is overexpressed in many human malignancies, including breast cancer,(5)…”
BackgroundActivation of ARF by oncogenic stress in mouse fibroblasts is independent of E2F1 and E2F2
Palmero, I., Murga, M., Zubiaga, A. M., & Serrano, M. (2002) · Oncogene · doi:10.1038/sj.onc.1205371 · Cited by 46
“The positive regulators include Myc (Zindy et al., 1998), and DMP1 (Inoue et al., 1999, 2000); and the negative regulators include p53 (Stott et al., 1998; Robertson and Jones, 1998), Twist (Maestro et al., 1999), Bmi-1 (Jacobs et al., 1999), JunD (Weitzman et al., 2000), TBX2 (Jacobs et al., 2000) and TBX3 (Brummelka…”
Transient requirements of YY1 expression for PcG transcriptional repression and phenotypic rescue
Srinivasan, L., Pan, X., & Atchison, M. L. (2005) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20562 · Cited by 38
“A variety of vertebrate PcG proteins have been identified that function similar to their Drosophila counterparts and regulate hox gene expression, skeletal development, hematopoiesis, neural development, cell growth control, chromatin remodeling, histone modification, and transcriptional repression [van der Lugt et al…”
BackgroundZhou, L., Zhang, W., Wang, D., Tao, K., Song, W., & Ke-feng, D. (2014) · Oncology Reports · doi:10.3892/or.2014.3374 · Cited by 34
Downregulated miR-495 Inhibits the G1-S Phase Transition by Targeting Bmi-1 in Breast Cancer
Wang, L., Liu, J., Yu, L., Liu, X., Wu, H., Lei, F., Wu, S., & Wang, X. (2015) · Medicine · doi:10.1097/md.0000000000000718 · Cited by 34
Expression of theArftumor suppressor gene is controlled by Tgfβ2 during development
Freeman-Anderson, N. E., Zheng, Y., McCalla-Martin, A. C., Treanor, L. M., Zhao, Y. D., Garfin, P. M., He, T., Mary, M. N., Thornton, J. D., Anderson, C., et al. (2009) · Development · doi:10.1242/dev.033548 · Cited by 36
“The activity of certain Polycomb group proteins (notably Bmi1) leads to the methylation and silencing of Arf, Ink4a and to a lesser extent Ink4b in MEFs (Jacobs et al., 1999).”
BackgroundZhang, X., Yang, X., Zhang, Y., Liu, X., Zheng, G., Yang, Y., Wang, L., Du, L., & Wang, C. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-1761 · Cited by 35
“Like other PcG groupmembers, Bmi-1 functions as a transcriptional repressor that regulates inhibitors of cyclin-dependent kinase inhibitor, p16Ink4a, and a p53 regulator, p14Arf, to prevent premature senescence (7).”
BackgroundThe altered fate of aging satellite cells is determined by signaling and epigenetic changes
Parker, M. H. (2015) · Frontiers in Genetics · doi:10.3389/fgene.2015.00059 · Cited by 42
“Bmi1, a component of the PRC1 complex, represses expression of p16INK4A, and has been suggested to play an important role in delaying aging by preventing cellular senescence (Jacobs et al., 1999).”
BackgroundSuzuki, T., & Nohara, K. (2012) · Journal of Applied Toxicology · doi:10.1002/jat.2765 · Cited by 34
B-MYB delays cell aging by repressing p16 INK4α transcription
Huang, Y., Wu, J., Li, R., Wang, P., Han, L., Zhang, Z., & Tong, T. (2010) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-010-0501-9 · Cited by 36
“In the locus control level, Bmi-1, a transcriptional repressor belonging to the Polycomb group gene family, represses INK4a locus, which encodes the p16 and p14, and overcomes the p16-dependent senescence [16, 17].”
BackgroundPTEN Mediates Activation of Core Clock Protein BMAL1 and Accumulation of Epidermal Stem Cells
Zagni, C., Almeida, L. O., Balan, T., Martins, M. A. T., Rosselli‐Murai, L. K., Papagerakis, P., CASTILHO, R. M., & SQUARIZE, C. H. (2017) · Stem Cell Reports · doi:10.1016/j.stemcr.2017.05.006 · Cited by 34
“In contrast, BMI-1 overexpression triggers an oncogenic effect mediated by p16ink4 suppression and subsequent pRB and p53 signaling activation (Jacobs et al., 1999a, 1999b).”
BackgroundE2f6 and Bmi1 cooperate in axial skeletal development
Courel, M., Friesenhahn, L., & Lees, J. A. (2008) · Developmental Dynamics · doi:10.1002/dvdy.21516 · Cited by 34
“Additionally, Bmi1-deficient mice have impaired proliferation and premature senescence due to the up-regulation of Ink4a-Arf (Jacobs et al., 1999).”
BackgroundMolecular abnormalities in Ewing’s sarcoma
Burchill, S. A. (2008) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.8.10.1675 · Cited by 34
Epigenome programming by Polycomb and Trithorax proteins
Cernilogar, F. M., & Orlando, V. (2005) · Biochemistry and Cell Biology · doi:10.1139/o05-040 · Cited by 38
Redox-dependent BMI1 activity drives in vivo adult cardiac progenitor cell differentiation
Herrero, D., Tomé, M., Cañón, S., Cruz, F. M., Carmona, R. M., Fuster, E., Roche, E., & Bernad, A. (2018) · Cell Death and Differentiation · doi:10.1038/s41418-017-0022-2 · Cited by 33
de Smith, A. J., Walsh, K. M., Francis, S. S., Zhang, C., Hansen, H. M., Smirnov, I. V., Morimoto, L. M., Whitehead, T. P., Kang, A. Y., Shao, X., et al. (2018) · International Journal of Cancer · doi:10.1002/ijc.31622 · Cited by 35
Nuclear PTHrP targeting regulates PTHrP secretion and enhances LoVo cell growth and survival
Bhatia, V., Saini, M. K., & Falzon, M. (2009) · Regulatory Peptides · doi:10.1016/j.regpep.2009.07.008 · Cited by 33
“Mice expressing PTHrP deleted over the NLS/C-terminal domain also had lower nuclear levels of Bim-1, a protein which promotes cell proliferation and suppresses genes that induce cellular senescence and cell death [30].”
BackgroundBhattacharyya, J., Mihara, K., Ohtsubo, M., Yasunaga, S., Takei, Y., Yanagihara, K., Sakai, A., Hoshi, M., Takihara, Y., & Kimura, A. (2011) · Cancer Science · doi:10.1111/j.1349-7006.2011.02121.x · Cited by 34
BMI-1 suppresses contact inhibition and stabilizes YAP in Ewing sarcoma
Hsu, J. H., & Lawlor, E. R. (2010) · Oncogene · doi:10.1038/onc.2010.571 · Cited by 36
“BMI-1 promotes stem cell self-renewal and malignant transformation in part via epigenetic repression of the CDKN2A locus, thus inhibiting expression of the cell cycle inhibitors p16INK4A and p14ARF (Jacobs et al., 1999a, b).”
Bmi-1 extends the life span of normal human oral keratinocytes by inhibiting the TGF-β signaling
Kim, R. H., Lieberman, M. B., Lee, R., Shin, K.-H., Mehrazarin, S., Oh, J.-E., Park, N., & Kang, M. (2010) · Experimental Cell Research · doi:10.1016/j.yexcr.2010.04.013 · Cited by 33
“Earlier studies showed that Bmi-1 inhibited senescence and extended the lifespan of normal human cells by repressing p16INK4A [2,3].”
BackgroundUBAP2L is a novel BMI1-interacting protein essential for hematopoietic stem cell activity
Bordeleau, M.-È., Aucagne, R., Chagraoui, J., Girard, S., Mayotte, N., Bonneil, É., Thibault, P., Pabst, C., Bergeron, A., Barabé, F., et al. (2014) · Blood · doi:10.1182/blood-2014-01-548651 · Cited by 33
hafez, A. A. E., & El-Hadaad, H. A. (2013) · Annals of Diagnostic Pathology · doi:10.1016/j.anndiagpath.2013.11.004 · Cited by 33
“The p16INK4a protein inhibits binding of cyclin D to CDK4/6, resulting in the suppression of retinoblastoma activity and induction of cell cycle arrest [12,13], whereas p14ARF induces p53 and causes cell cycle arrest [12-14].”
BackgroundOverexpression of Bmi-1 in uterine cervical cancer: correlation with clinicopathology and prognosis.
Zhang, X., Wang, C., Zhu, C., Zhang, J., Kan, S., Du, L., Li, W., Wang, L., & Wang, S. (2010) · PubMed · Cited by 35
Gasser, S. M., & Li, E. (2010) · Springer eBooks · doi:10.1007/978-3-7643-8989-5 · Cited by 33
“and CBX7 [52, 53].”
BackgroundInfluentialHarada, Y., Inoue, D., Ding, Y., Imagawa, J., Doki, N., Matsui, H., Yahata, T., Matsushita, H., Ando, K., Sashida, G., et al. (2013) · Blood · doi:10.1182/blood-2012-06-434423 · Cited by 34
MDR1 mediated chemoresistance: BMI1 and TIP60 in action
Mustafi, S. B., Chakraborty, P. K., Naz, S., Dwivedi, S. K. D., Street, M., Basak, R., Yang, D., Ding, K., Mukherjee, P., & Bhattacharya, R. (2016) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2016.06.002 · Cited by 32
González‐Gil, C., Ribera, J., Ribera, J., & Genescà, E. (2021) · Genes · doi:10.3390/genes12010079 · Cited by 33
“However, CDKN2A/B deletions do not occur in CML; probably because the leukemia arises from HSC-like progenitors [123,125], in which the CDKN2A/B locus is epigenetically silenced and “poised” to respond to an abnormally higher and sustained threshold of hyperproliferative signals [122].”
BackgroundChen, M. H., Fu, L., Zhang, F., Yang, Y., & Wu, X. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119748 · Cited by 35
Gialmanidis, I. P., Bravou, V., Petrou, I., Kourea, H. P., Mathioudakis, A. G., Lilis, I., & Papadaki, H. H. (2013) · Lung · doi:10.1007/s00408-013-9490-4 · Cited by 32
“Bmi1, a member of the polycomb group proteins, has been implicated in embryonic development, differentiation, and stem cell maintenance [11–14].”
BackgroundBmi1 in development and tumorigenesis of the central nervous system
Shakhova, O., Leung, C., & Marino, S. (2005) · Journal of Molecular Medicine · doi:10.1007/s00109-005-0682-0 · Cited by 32
“Histopathological analysis revealed a normal architecture of the brain but a significant reduction of the overall size, which was particularly severe in the cerebellum wherein reduced cellularity of the granular and molecular layers were most pronounced [10].”
BackgroundSelf-citationTreanor, L. M., Volanakis, E. J., Zhou, S., Lu, T., Sherr, C. J., & Sorrentino, B. P. (2011) · Blood · doi:10.1182/blood-2010-09-309831 · Cited by 36
Chatoo, W., Abdouh, M., Duparc, R.-H., & Bernier, G. (2010) · Stem Cells · doi:10.1002/stem.462 · Cited by 35
Chen, C., Chiou, S., Huang, C., Jan, C.-I., Lin, S., Tsai, M., & Lo, J. (2009) · Journal of Biomedical Science · doi:10.1186/1423-0127-16-100 · Cited by 32
“The oncogenic function of Bmi1 is mainly believed to be associated with its repressive effect on the Ink4a/Arf tumor suppressor locus and p53/p21 pathway, both of which plays critical roles in the onset of cellular senescence in many different types of human somatic cells [29,30].”
BackgroundWu, K. (2011) · PubMed · Cited by 37
Retinal development anomalies and cone photoreceptors degeneration upon Bmi1 deficiency
Barabino, A., Plamondon, V., Abdouh, M., Chatoo, W., Flamier, A., Hanna, R., Zhou, S., Motoyama, N., Hébert, M., Lavoie, J., et al. (2016) · Development · doi:10.1242/dev.125351 · Cited by 34
“Bmi1 mice show axial skeleton defects, reduced post natal growth and lifespan, and progressive cerebellar degeneration (Jacobs et al., 1999; van der Lugt et al., 1994).”
BackgroundP16INK4a upregulation mediated by TBK1 induces retinal ganglion cell senescence in ischemic injury
Li, L. U., Zhao, Y., & Zhang, H. (2017) · Cell Death & Disease · doi:10.1038/cddis.2017.169 · Cited by 34
“Bmi1deficient primary mouse embryonic fibroblasts are impaired in progression into the S phase of the cell cycle and undergo premature senescence.(14) In addition, Bmi1 can be phosphorylated at different serine residues, modulating its function through the Ink/Arf pathway beyond the cellular level.”
BackgroundChen, M., Pereira‐Smith, O. M., & Tominaga, K. (2011) · Stem Cell Research · doi:10.1016/j.scr.2011.04.002 · Cited by 32
“1C) by qRT-PCR, since these other cell cycle regulators have been shown to be important in stem cell self-renewal (Jacobs et al., 1999; Molofsky et al., 2006; Nishino et al., 2008).”
Cellular senescence, an unpopular yet trustworthy tumor suppressor mechanism
Ishikawa, F. (2003) · Cancer Science · doi:10.1111/j.1349-7006.2003.tb01382.x · Cited by 34
Mouse Models for Sporadic Cancer
Meuwissen, R. L. J., Jonkers, J., & Berns, A. J. M. (2001) · Experimental Cell Research · doi:10.1006/excr.2000.5146 · Cited by 32
CIP/KIP and INK4 families as hostages of oncogenic signaling
Csergeová, L., Krbušek, D., & Janoštiak, R. (2024) · Cell Division · doi:10.1186/s13008-024-00115-z · Cited by 33
“As previously mentioned, polycomb repressive complexes are critical for the repression of the INK4/ARF locus and subsequent senescence delay via catalyzing histone H3 Lys27 trimethylation [243, 244].”
BackgroundDalley, A. J., Pitty, L. P., Major, A. G., AbdulMajeed, A. A., & Farah, C. S. (2014) · Cancer Medicine · doi:10.1002/cam4.182 · Cited by 31
“Bmi-1 (B lymphoma MoMLV insertion region 1 homolog) contributes to the epigenetic regulation of cell cycle and senescence of tissue stem cells via the INK4A loci [17].”
BackgroundLoss of AML1/Runx1 accelerates the development of MLL-ENL leukemia through down-regulation of p19ARF
Nishimoto, N., Arai, S., Ichikawa, M., Nakagawa, M. M., Goyama, S., Kumano, K., Takahashi, T., Kamikubo, Y., Imai, Y., & Kurokawa, M. (2011) · Blood · doi:10.1182/blood-2010-10-315440 · Cited by 35
Aberrant expression of p14 ARF in human cancers: A new biomarker?
Inoue, K., & Fry, E. A. (2018) · Tumor and Microenvironment · doi:10.4103/tme.tme_24_17 · Cited by 33
Tzekaki, E. E., Papaspyropoulos, A., Tsolaki, M., Lazarou, E., Kozori, M., & Pantazaki, Α. A. (2020) · Experimental Gerontology · doi:10.1016/j.exger.2020.111178 · Cited by 36
Polycomb Repressive Complex(es) and Their Role in Adult Stem Cells
Flora, P., Dalal, G., Cohen, I., & Ezhkova, E. (2021) · Genes · doi:10.3390/genes12101485 · Cited by 31
Hwang, C., Nieh, S., Lai, C., Tsai, C.-S., Chang, L., Hua, C., Chi, W., Chien, H., Wang, C., Chan, S., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0105676 · Cited by 31
“Bmi-1, a polycomb-group protein, regulates gene expression by chromatin remodeling, and control of axial patterning, cell proliferation, and senescence [25–26].”
p16 Is upregulated in proliferative inflammatory atrophy of the prostate
Faith, D., Han, S., Lee, D. K., Friedl, A., Hicks, J. L., Marzo, A. M. D., & Jarrard, D. F. (2005) · The Prostate · doi:10.1002/pros.20258 · Cited by 33
“Other candidates for altering p16 function include the bmi-1 oncoprotein [47], and Cdc37, an (1)De Marzo et al.”
Clinical significance of cell cycle inhibitors in hepatocellular carcinoma
Matsuda, Y., Wakai, T., Kubota, M., Takamura, M., Yamagiwa, S., Aoyagi, Y., Osawa, M., Fujimaki, S., Sanpei, A., Genda, T., et al. (2013) · Medical Molecular Morphology · doi:10.1007/s00795-013-0047-7 · Cited by 34
“A second player is BMI-1 (B lymphoma MoMLV insertion region 1 homolog), a transcriptional repressor belonging to the mouse Polycomb group [31].”
Govindarajan, B., Shah, A., Cohen, C., Arnold, R. S., Schechner, J. S., Chung, J., Mercurio, A. M., Alani, R. M., Ryu, B., Fan, C., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500411200 · Cited by 31
Tumor suppressor mechanisms in immune aging
Liu, Y., & Sharpless, N. E. (2009) · Current Opinion in Immunology · doi:10.1016/j.coi.2009.05.011 · Cited by 30
Bouzahzah, B., Fu, M., Iavarone, A., Factor, V. M., Thorgeirsson, S. S., & Pestell, R. G. (2000) · PubMed · Cited by 38
Gao, M., Zhang, T., Chen, T., Chen, Z., Zhu, Z., Wen, Y., Qin, S., Bao, Y., Zhao, T., Li, H., et al. (2024) · Theranostics · doi:10.7150/thno.89878 · Cited by 28
“However, bcKO mice in our study maintained normal folliculogenesis at 8 months, indicating that BMI1 was more crucial in oocytes than GCs. p16 and p19 are the most canonical loci targeted by BMI1 or MEL18 [60-62].”
BackgroundMantle Cell Lymphoma: Biological Insights and Treatment Advances
Leonard, J. P., Williams, M. E., Goy, A. H., Grant, S., Pfreundschuh, M. G., Rosen, S. T., & Sweetenham, J. W. (2009) · Clinical Lymphoma & Myeloma · doi:10.3816/clm.2009.n.055 · Cited by 33
Vékony, H., Röser, K., Löning, T., Raaphorst, F. M., Leemans, C. R., van der Waal, I., & Bloemena, E. (2008) · Histopathology · doi:10.1111/j.1365-2559.2008.03184.x · Cited by 30
Association between Bmi1 and clinicopathological status of esophageal squamous cell carcinoma
He, X., Cao, X., Ji, L., Zhu, B., Lv, J., Wang, D., Lu, P., & Cui, H.-G. (2009) · World Journal of Gastroenterology · doi:10.3748/wjg.15.2389 · Cited by 30
Prostate Tumorigenesis Induced by PTEN Deletion Involves Estrogen Receptor β Repression
Mak, P., Li, J., Samanta, S., Chang, C., Jerry, D. J., Davis, R. J., Leav, I., & Mercurio, A. M. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.02.063 · Cited by 30
“The results presented in this study validate this hypothesis and provide a mechanism for how PTEN loss results in the transcriptional repression of ERb that involves BMI-1, an oncogene that regulates cell proliferation and senescence through the ink4a locus (Jacobs et al., 1999) and has been implicated in prostate tum…”
Adult neural stem cells and their role in brain pathology
Yadırgı, G., & Marino, S. (2008) · The Journal of Pathology · doi:10.1002/path.2480 · Cited by 33
“In the absence of Bmi1, both products of the Ink4a/Arf locus are highly expressed [43].”
BackgroundSelf-citationBmi-1 Absence Causes Premature Brain Degeneration
Cao, G., Gu, M., Zhu, M., Gao, J., Yin, Y., Marshall, C., Xiao, M., Ding, J., & Miao, D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032015 · Cited by 31
“It is implicated in cell cycle regulation and cell senescence by repression of Ink4a/Arf locus, encoding cell cycle regulators p16Ink4a and p19Arf [1,2,3,4,5,6].”
BackgroundPancreatic cancer stem cells and relevance to cancer treatments
Bednar, F., & Simeone, D. M. (2009) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22093 · Cited by 30
“When Bmi-1 is deleted, p16 and p19 cyclin-dependent kinase inhibitor expression is amplified, leading to premature cellular senescence [Jacobs et al., 1999].”
BackgroundMAPKAP kinase MK2 maintains self‐renewal capacity of haematopoietic stem cells
Schwermann, J., Rathinam, C., Schubert, M., Schumacher, S., Noyan, F., Koseki, H., Kotlyarov, A., Klein, C., & Gaestel, M. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.100 · Cited by 32
“Interestingly, in contrast to Bmi1-deficient stem cells, the Ink4a locus as a downstream target of Bmi1 (Jacobs et al, 1999; Park et al, 2003), encoding p16Ink4a and p19Arf under the control of two distinct promoters (Quelle et al, 1995), is selectively affected in MK2-deficient HSC: Only the…”
BackgroundInfluentialEpigenetic Modifiers in Normal and Malignant Hematopoiesis
Haladyna, J. N., Yamauchi, T., Neff, T., & Bernt, K. M. (2015) · Epigenomics · doi:10.2217/epi.14.88 · Cited by 31
Lee, J. Y., Yu, K., Kim, H., Kang, I., Kim, J.-J., Lee, B., Choi, S. W., Shin, J., Seo, Y., & Kang, K. (2016) · Aging · doi:10.18632/aging.101000 · Cited by 31
“Mice deficient in Bmi1 show premature senescence and a decreased life span, as well as a loss of mitochondrial function accompanied by increased reactive oxygen species (ROS) levels and the activation of DNA damage responses [29, 30].”
BackgroundKamarudin, M. N. A., & Parhar, I. S. (2019) · Oncotarget · doi:10.18632/oncotarget.26994 · Cited by 31
“The overexpression of Bmi1 promotes cancer invasion and metastasis as observed in various cancer models [60–62], and can suppress the cellular senescence in immortalized mouse embryonic fibroblasts through the repression of the Ink4a/Arf-locus [63, 64].”
BackgroundLong Noncoding RNA ANRIL as a Novel Biomarker in Human Cancer
Lou, N., Liu, G., & Pan, Y. (2020) · Future Oncology · doi:10.2217/fon-2020-0470 · Cited by 33
Non-Canonical Functions of the ARF Tumor Suppressor in Development and Tumorigenesis
Lаgopati, N., Belogiannis, K., Angelopoulou, A., Papaspyropoulos, A., & Gorgoulis, V. G. (2021) · Biomolecules · doi:10.3390/biom11010086 · Cited by 33
“Jacobs et al. (1999) demonstrated that in Bmi1-deficient mouse embryonic fibroblasts and lymphocytes undergoing premature senescence, the expression of both p16INK4a and p19ARF was markedly increased, while Bmi1 overexpression led to fibroblast immortalization and a decrease in p16INK4A and p19ARF…”
BackgroundInfluentialOgata, R., Matsueda, S., Yao, A., Noguchi, M., Itoh, K., & Harada, M. (2004) · The Prostate · doi:10.1002/pros.20078 · Cited by 30
Zhao, X., Li, J., Liu, Z., & Powers, S. (2021) · Cancer Research · doi:10.1158/0008-5472.can-21-2555 · Cited by 31
“However, this functional distinction was later blurred by the experiments showing that overexpression of BMI1 or homozygous deletion of CDKN2A could cooperate with both mutant HRAS and MYC in transforming primary rodent fi broblasts (54, 55).”
Xu, N., Li, Y.-L., Zhou, X., Cao, R., Li, H., Lu, Q., Li, L., Lu, Z., Huang, J., Sun, J., et al. (2015) · Journal of Cancer · doi:10.7150/jca.11959 · Cited by 29
“[2-4].”
Pina, C., & Enver, T. (2007) · Oncogene · doi:10.1038/sj.onc.1210759 · Cited by 39
“Overexpression of p16 induces a G1-to-S phase progression block, while high levels of p19 cause p53-dependent growth arrest and apoptosis; both factors are implicated in cell senescence (Jacobs et al., 1999).”
Senescence suppressors: their practical importance in replicative lifespan extension in stem cells
Hwang, E. S. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1685-1 · Cited by 32
David-Pfeuty, T. (2005) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2005.08.008 · Cited by 37
Balasubramanian, S., Lee, K., Adhikary, G., Gopalakrishnan, R., Rorke, E. A., & Eckert, R. L. (2008) · Nutrition Reviews · doi:10.1111/j.1753-4887.2008.00071.x · Cited by 29
UbE2E1/UBCH6 Is a Critical in Vivo E2 for the PRC1-catalyzed Ubiquitination of H2A at Lys-119
Wheaton, K., Sarkari, F., Johns, B. S., Davarinejad, H., Egorova, O., Kaustov, L., Raught, B., Saridakis, V., & Sheng, Y. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.749564 · Cited by 31
Gergely, J. E., Dorsey, A. E., Dimri, G. P., & Dimri, M. (2018) · Molecular Carcinogenesis · doi:10.1002/mc.22804 · Cited by 29
Wang, Y., Lv, H., Xu, Z., Sun, J., Ni, Y., Chen, Z., & Cheng, X. (2019) · Scientific Reports · doi:10.1038/s41598-018-36940-w · Cited by 29
Metadata
- Authors
- Jacobs, J. J. L., Kieboom, K., Marino, S., DePinho, R. A., & van Lohuizen, M.
- Affiliations
- The Netherlands Cancer Institute (NL)
- Harvard University (US)
- Venue
- Nature
- Published
- 1999-01
- Volume
- 397
- Issue
- 6715
- Pages
- 164-168
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1481473039
- Cited by
- 1,580
- References
- 30
- Citations by year
- 2026: 12 · 2025: 15 · 2024: 24 · 2023: 29 · 2022: 36 · 2021: 36 · 2020: 42 · 2019: 43 · 2018: 42 · 2017: 53 · 2016: 71 · 2015: 76 · 2014: 76 · 2013: 76 · 2012: 86
- FWCI
- 16.77
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Institutes of Health
- National Institute of Neurological Disorders and Stroke
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Keywords
- BMI1, Polycomb group proteins, p16, p19ARF, cellular senescence, cell proliferation, cell cycle progression, S phase, transcriptional repression, lymphoma, lymphoid cells, neurological deficit, H-Ras, oncogenic transformation, tumor suppressor
- MeSH terms
- Animals, Cell Cycle, Cell Division, Cells, Cultured, Fibroblasts, Gene Expression Regulation, Humans, Nuclear Proteins, Oncogenes, Proteins, Proto-Oncogene Proteins, Repressor Proteins, Genes, Tumor Suppressor, Cellular Senescence, Mice, Knockout, Cyclin-Dependent Kinase Inhibitor p16, Tumor Suppressor Protein p14ARF, Mice, Polycomb Repressive Complex 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.